MedTech Dive November 17, 2023
Nick Paul Taylor

The agency published a paper on improving the evaluation of pulse oximeters to take skin pigmentation into account.

Dive Brief:

  • The Food and Drug Administration is seeking feedback on the use of pulse oximeters in people with darker skin pigmentation ahead of an advisory committee meeting next year.
  • The agency, under pressure to mitigate the risk of bias, published a discussion paper on improving the performance evaluation of pulse oximeters, taking skin pigmentation, race and ethnicity into account.
  • Feedback on the paper will inform the virtual public meeting of an advisory committee that the FDA has scheduled for February. The committee will discuss how to improve premarket studies and the type and amount of data that developers of pulse...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article